论文部分内容阅读
采用自血光量子疗法（血疗）加补阳还五汤加减及西药联合治疗缺血性中风２６８例（治疗组），并与单纯西药治疗１３４例（对照组）作对照观察，比较两组患者的临床疗效。两组所用西药相同，治疗２０天，进行疗效评定。结果：总有效率治疗组９６．３％，对照组８６．６％，差异非常显著（Ｐ＜０．０１）。治疗组患者血胆固醇由治疗前的４．４１±０．７６ｍｍｏｌ／Ｌ降至３．７３±０．６３ｍｍｏｌ／Ｌ，甘油三酯由治疗前的１．７１±０．３５ｍｍｏｌ／Ｌ降至１．４９±０．２１ｍｍｏｌ／Ｌ，血糖由治疗前的７．２０±１．２８ｍｍｏｌ／Ｌ降至５．９０±１．３０ｍｍｏｌ／Ｌ，Ｐ均＜０．０１；总有效率治疗组为６９．８％，对照组为４３．６％，两组比较Ｐ＜０．０１。对照组胆固醇、甘油三酯、血糖水平治疗前后比较无显著性差异，Ｐ均＞０．０５。作者认为：中风发生后，如何迅速改善病灶及其周围组织的血氧供应，是使脑细胞功能恢复的关键。血疗能增加血氧饱和度，提高超氧化物歧化酶活性，减少自由基损伤；补阳还五汤加味能补气活血化瘀，通经活络；西药均能减轻脑水肿，改善脑循环。三者合用有利于急性期缺血性中风临床症状和体征的改善，从而提高了疗效
A total of 268 cases of ischemic stroke (treated group) were treated with blood phototherapy (BLM) plus BYHWD plus and minus western medicine, and 134 cases (control group) with western medicine alone were compared. The patients in two groups were compared The clinical efficacy. Western medicine used in both groups the same treatment for 20 days, the efficacy evaluation. Results: The total effective rate was 96.3% in the treatment group and 86.6% in the control group, the difference was significant (P <0.01). Blood cholesterol in the treatment group decreased from 4.41 ± 0.76mmol / L before treatment to 3.73 ± 0.63mmol / L, and triglyceride dropped to 1. from 1.71 ± 0.35mmol / L before treatment. 49 ± 0.21mmol / L, blood glucose decreased from 7.20 ± 1.28mmol / L before treatment to 5.90 ± 1.30mmol / L, both P <0.01; the total effective rate was 69.8 %, Control group was 43.6%, P <0.01. There were no significant differences in cholesterol, triglyceride and blood glucose before and after treatment in control group, P> 0.05. The author believes that: stroke, how to quickly improve the lesion and its surrounding tissue oxygen supply, is the key to the recovery of brain cell function. Blood treatment can increase oxygen saturation, increase superoxide dismutase activity, reduce free radical damage; Buyang Huanwu Decoction can nourishing qi and activating blood circulation, pass through the meridians; Western medicine can reduce cerebral edema and improve cerebral circulation. Combination of the three is conducive to the improvement of clinical symptoms and signs of acute ischemic stroke, thereby enhancing the efficacy